Also trades as: 3933.HK (HKSE) · $vol 7M
ULIHF OTC
The United Laboratories International Holdings Limited
1W: +5.9%
1M: -2.7%
3M: +14.8%
YTD: -42.5%
1Y: -52.6%
3Y: +42.9%
5Y: +70.2%
$1.07
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$30.9B
+19.7% ▲
5Y CAGR: +15.6%
Total Liabilities
$13.3B
+17.1% ▲
5Y CAGR: +16.0%
Shareholders Equity
$17.4B
+20.9% ▲
5Y CAGR: +15.1%
Cash & Investments
$11.2B
+77.6% ▲
5Y CAGR: +30.3%
Total Debt
$5.0B
+58.3% ▲
5Y CAGR: +17.7%
Net Debt
-$6.2B
-96.8% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $3.3B | $4.7B | $4.3B | $6.3B | $11.2B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $3.3B | $4.7B | $4.3B | $6.3B | $11.2B |
| Net Receivables | $3.4B | $4.5B | $5.9B | $6.0B | $4.6B |
| Inventory | $2.0B | $2.2B | $2.2B | $2.4B | $2.4B |
| Other Current Assets | $1.2B | $1.1B | $1.4B | $1.3B | $275M |
| Total Current Assets | $10.0B | $12.5B | $13.8B | $16.1B | $18.5B |
| Property, Plant & Equip. | $6.1B | $6.2B | $6.9B | $9.5B | $12.1B |
| Goodwill & Intangibles | $8M | $6M | $5M | $223M | $277M |
| Long-Term Investments | $500K | $8M | $8M | $7M | $7M |
| Other Non-Current Assets | -$83M | -$80M | $343M | $0 | $4M |
| Total Non-Current Assets | $6.1B | $6.2B | $7.2B | $9.8B | $12.4B |
| Total Assets | $16.3B | $19.0B | $21.0B | $25.8B | $30.9B |
| — Liabilities — | |||||
| Accounts Payable | $3.2B | $3.6B | $4.2B | $4.2B | $3.8B |
| Short-Term Debt | $1.6B | $1.4B | $198M | $830M | $2.1B |
| Deferred Revenue | -$1.6B | -$1.4B | $0 | $0 | $77M |
| Other Current Liabilities | $2.7B | $2.7B | $1.4B | $1.1B | $3.7B |
| Total Current Liabilities | $6.5B | $7.0B | $6.6B | $8.8B | $10.1B |
| Long-Term Debt | $221M | $1.1B | $1.3B | $2.3B | $2.9B |
| Other Non-Current Liab. | $0 | $0 | $19M | $0 | $7 |
| Total Non-Current Liabilities | $456M | $1.3B | $1.6B | $2.6B | $3.3B |
| Total Liabilities | $7.0B | $8.4B | $8.3B | $11.4B | $13.3B |
| — Equity — | |||||
| Common Stock | $17M | $17M | $17M | $17M | $18M |
| Retained Earnings | $5.3B | $6.6B | $7.3B | $8.8B | $0 |
| Accumulated OCI | $285M | $286M | $1.7B | $1.9B | $0 |
| Total Stockholders Equity | $9.3B | $10.6B | $12.7B | $14.4B | $17.4B |
| Total Liabilities & Equity | $16.3B | $19.0B | $21.0B | $25.8B | $30.9B |
| — Key Metrics — | |||||
| Total Debt | $1.8B | $2.5B | $1.5B | $3.2B | $5.0B |
| Net Debt | -$1.5B | -$2.3B | -$2.8B | -$3.2B | -$6.2B |
| Total Investments | $500K | $8M | $8M | $7M | $7M |